Keith M Sigel1, Kimberly Stone1, Juan P Wisnivesky1, Lesley S Park2, Chung Yin Kong3, Michael J Silverberg4,5, Sheldon Brown1,6, Matthew Goetz7,8, Maria C Rodriguez-Barradas9, Cynthia Gibert10, Fatma Shebl11, Roger Bedimo12, Roxanne Wadia13, Joseph King13,14, Kristina Crothers15. 1. Icahn School of Medicine at Mount Sinai, New York, New York. 2. Stanford University School of Medicine, Palo Alto, California. 3. Institute for Technology Assessment, Massachusetts General Hospital, Boston, Massachusetts. 4. Kaiser Permanente Northern California, Oakland, California. 5. University of Washington School of Medicine, Seattle, Washington, District of Columbia. 6. James J Peters VA Medical Center, Bronx, New York, New York. 7. VA Greater Los Angeles Healthcare System. 8. David Geffen School of Medicine at UCLA, Los Angeles, California. 9. Michael E. DeBakey VA Medical Center and Baylor University School of Medicine, Houston, Texas. 10. Washington DC VA Medical Center and George Washington University School of Medicine, Washington, District of Columbia. 11. Massachussets General Hospital, Boston, Massachusetts. 12. VA North Texas Healthcare Center and University of Texas Southwestern School of Medicine, Dallas, Texas. 13. VA Connecticut Healthcare System, West Haven. 14. Yale University School of Medicine, New Haven, Connecticut. 15. University of Washington School of Medicine, Seattle, Washington, District of Columbia, USA.
Abstract
OBJECTIVE: Lung cancer is the leading cause of cancer death in people living with HIV (PWH). Surgical resection is a key component of potentially curative treatment regimens for early-stage lung cancers, but its safety is unclear in the setting of HIV. From a national cohort, we assessed potential differences in the risk of major lung cancer surgery complications by HIV status. DESIGN: We linked clinical and cancer data from the Veterans Aging Cohort Study (VACS) and Veterans Affairs Corporate Data Warehouse to outcomes from the Veterans Affairs Surgical Quality Improvement Program (VASQIP) and identified 8371 patients (137 PWH, 8234 uninfected) who underwent lung cancer surgeries between 2000 and 2016. METHODS: We compared rates of 15 major short-term surgical complications by HIV status. RESULTS: Use of surgical resection for early-stage lung cancer did not differ by HIV status. Lung cancer surgery postoperative (30-day) mortality was 2.0% for PWH and did not differ by HIV status (P = 0.9). Pneumonia was the most common complication for both PWH and uninfected veterans, but did not differ significantly in prevalence between groups (11.0% for PWH versus 9.4%; P = 0.5). The frequency of complications did not differ by HIV status for any complication (all P > 0.3). There were no significant predictors of postoperative complications for PWH. CONCLUSIONS: In a national antiretroviral-era cohort of lung cancer patients undergoing surgical lung resection, short-term outcomes after surgery did not differ significantly by HIV status. Concerns regarding short-term surgical complications should have limited influence on treatment decisions for PWH with lung cancer.
OBJECTIVE:Lung cancer is the leading cause of cancer death in people living with HIV (PWH). Surgical resection is a key component of potentially curative treatment regimens for early-stage lung cancers, but its safety is unclear in the setting of HIV. From a national cohort, we assessed potential differences in the risk of major lung cancer surgery complications by HIV status. DESIGN: We linked clinical and cancer data from the Veterans Aging Cohort Study (VACS) and Veterans Affairs Corporate Data Warehouse to outcomes from the Veterans Affairs Surgical Quality Improvement Program (VASQIP) and identified 8371 patients (137 PWH, 8234 uninfected) who underwent lung cancer surgeries between 2000 and 2016. METHODS: We compared rates of 15 major short-term surgical complications by HIV status. RESULTS: Use of surgical resection for early-stage lung cancer did not differ by HIV status. Lung cancer surgery postoperative (30-day) mortality was 2.0% for PWH and did not differ by HIV status (P = 0.9). Pneumonia was the most common complication for both PWH and uninfected veterans, but did not differ significantly in prevalence between groups (11.0% for PWH versus 9.4%; P = 0.5). The frequency of complications did not differ by HIV status for any complication (all P > 0.3). There were no significant predictors of postoperative complications for PWH. CONCLUSIONS: In a national antiretroviral-era cohort of lung cancerpatients undergoing surgical lung resection, short-term outcomes after surgery did not differ significantly by HIV status. Concerns regarding short-term surgical complications should have limited influence on treatment decisions for PWH with lung cancer.
Authors: Michael A Horberg; Leo B Hurley; Daniel B Klein; Stephen E Follansbee; Charles Quesenberry; Jason A Flamm; Gary M Green; Tye Luu Journal: Arch Surg Date: 2006-12
Authors: Meredith S Shiels; Jessica Y Islam; Philip S Rosenberg; H Irene Hall; Evin Jacobson; Eric A Engels Journal: Ann Intern Med Date: 2018-05-08 Impact factor: 25.391
Authors: Craig M Hooker; Robert A Meguid; Alicia Hulbert; Joshua T Taylor; James Shin; John Wrangle; Kristen Rodgers; Beverly Lee; Suvasini Laskshmanan; Travis Brown; Avedis Meneshian; Marc Sussman; Jeanne Keruly; Richard D Moore; Stephen C Yang; Malcolm V Brock Journal: Ann Thorac Surg Date: 2012-02 Impact factor: 4.330
Authors: Keith Sigel; Juan Wisnivesky; Shahida Shahrir; Sheldon T Brown; Amy Justice; Joon Kim; Maria C Rodriguez-Barradas; Kathleen M Akgün; David Rimland; Guy W Soo Hoo; Kristina Crothers Journal: AIDS Date: 2014-04-24 Impact factor: 4.177
Authors: Meredith S Shiels; Ruth M Pfeiffer; Mitchell H Gail; H Irene Hall; Jianmin Li; Anil K Chaturvedi; Kishor Bhatia; Thomas S Uldrick; Robert Yarchoan; James J Goedert; Eric A Engels Journal: J Natl Cancer Inst Date: 2011-04-11 Impact factor: 13.506
Authors: Gita Suneja; Meredith S Shiels; Sharon K Melville; Melanie A Williams; Ramesh Rengan; Eric A Engels Journal: AIDS Date: 2013-01-28 Impact factor: 4.177
Authors: Alain Makinson; Sabrina Eymard-Duvernay; François Raffi; Sophie Abgrall; Sébastien Bommart; David Zucman; Florent Valour; Antoine Cheret; Isabelle Poizot-Martin; Claudine Duvivier; Jean-Marc Mauboussin; Fabrice Bonnet; Pierre Tattevin; Jacques Reynes; Vincent Le Moing Journal: AIDS Date: 2016-02-20 Impact factor: 4.177
Authors: Janet P Tate; Amy C Justice; Michael D Hughes; Fabrice Bonnet; Peter Reiss; Amanda Mocroft; Jacob Nattermann; Fiona C Lampe; Heiner C Bucher; Timothy R Sterling; Heidi M Crane; Mari M Kitahata; Margaret May; Jonathan A C Sterne Journal: AIDS Date: 2013-02-20 Impact factor: 4.177